{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T15:33:19Z","timestamp":1784043199181,"version":"3.55.0"},"reference-count":88,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T00:00:00Z","timestamp":1766534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T00:00:00Z","timestamp":1766534400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003200","name":"Kementerian Sains, Teknologi dan Inovasi","doi-asserted-by":"publisher","award":["GA002-2021"],"award-info":[{"award-number":["GA002-2021"]}],"id":[{"id":"10.13039\/501100003200","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-28250-9","type":"journal-article","created":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T13:27:15Z","timestamp":1766582835000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Recombinant Bacillus subtilis spores expressing SARS-CoV-2 spike protein induced humoral, mucosal, and cellular immunity in mice"],"prefix":"10.1038","volume":"15","author":[{"given":"Atiqah","family":"Hazan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amalia A.","family":"Saperi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nurfatihah","family":"Zulkifli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nor-Aziyah","family":"MatRahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vunjia","family":"Tiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai-Yen","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sazaly","family":"AbuBakar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,24]]},"reference":[{"issue":"8","key":"28250_CR1","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1056\/NEJMoa2001017","volume":"382","author":"N Zhu","year":"2020","unstructured":"Zhu, N. et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl. J. Med. 382 (8), 727\u2013733 (2020).","journal-title":"N Engl. J. Med."},{"key":"28250_CR2","unstructured":"World Health Organization. WHO Coronavirus (COVID-19) Dashboard | WHO Coronavirus (COVID-19) dashboard with vaccination data [Internet]. 2025 [cited 2025 Jan 15]. Available from: https:\/\/covid19.who.int\/#"},{"issue":"7830","key":"28250_CR3","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/s41586-020-2639-4","volume":"586","author":"MJ Mulligan","year":"2020","unstructured":"Mulligan, M. J. et al. Phase I\/II study of COVID-19 RNA vaccine BNT162b1 in adults. Nature 586 (7830), 589\u2013593 (2020).","journal-title":"Nature"},{"issue":"19","key":"28250_CR4","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1056\/NEJMoa2110345","volume":"385","author":"SJ Thomas","year":"2021","unstructured":"Thomas, S. J. et al. Safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine through 6 months. N Engl. J. Med. 385 (19), 1761\u20131773 (2021).","journal-title":"N Engl. J. Med."},{"issue":"3","key":"28250_CR5","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1007\/s00134-021-06610-z","volume":"48","author":"MP Hilty","year":"2022","unstructured":"Hilty, M. P. et al. mRNA-based SARS-CoV-2 vaccination is associated with reduced ICU admission rate and disease severity in critically ill COVID-19 patients treated in Switzerland. Intensive Care Med. 48 (3), 62\u2013365 (2022).","journal-title":"Intensive Care Med."},{"issue":"20","key":"28250_CR6","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1001\/jama.2021.19499","volume":"326","author":"MW Tenforde","year":"2021","unstructured":"Tenforde, M. W. et al. Association between mRNA vaccination and COVID-19 hospitalization and disease severity. JAMA 326 (20), 2043\u20132054 (2021).","journal-title":"JAMA"},{"issue":"5","key":"28250_CR7","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1038\/s41385-022-00511-0","volume":"15","author":"S Sheikh-Mohamed","year":"2022","unstructured":"Sheikh-Mohamed, S. et al. Systemic and mucosal IgA responses are variably induced in response to SARS-CoV-2 mRNA vaccination and are associated with protection against subsequent infection. Mucosal Immunol. 15 (5), 799\u2013808 (2022).","journal-title":"Mucosal Immunol."},{"key":"28250_CR8","doi-asserted-by":"publisher","first-page":"96","DOI":"10.12688\/wellcomeopenres.17995.2","volume":"8","author":"S Clifford","year":"2023","unstructured":"Clifford, S. et al. Effectiveness of BNT162b2 and ChAdOx1 against SARS-CoV-2 household transmission: A prospective cohort study in England. Wellcome Open. Res. 8, 96 (2023).","journal-title":"Wellcome Open. Res."},{"issue":"8","key":"28250_CR9","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1056\/NEJMc2107717","volume":"385","author":"RJ Harris","year":"2021","unstructured":"Harris, R. J. et al. Effect of vaccination on household transmission of SARS-CoV-2 in England. N Engl. J. Med. 385 (8), 759\u2013760 (2021).","journal-title":"N Engl. J. Med."},{"issue":"1","key":"28250_CR10","doi-asserted-by":"publisher","first-page":"167","DOI":"10.3390\/v15010167","volume":"15","author":"S Chatterjee","year":"2023","unstructured":"Chatterjee, S., Bhattacharya, M., Nag, S., Dhama, K. & Chakraborty, C. A detailed overview of SARS-CoV-2 omicron: Its Sub-Variants, mutations and Pathophysiology, clinical Characteristics, immunological Landscape, immune Escape, and therapies. Viruses 15 (1), 167 (2023).","journal-title":"Viruses"},{"issue":"16","key":"28250_CR11","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1056\/NEJMoa2119451","volume":"386","author":"N Andrews","year":"2022","unstructured":"Andrews, N. et al. Covid-19 vaccine effectiveness against the Omicron (B.1.1.529) variant. N Engl. J. Med. 386 (16), 1532\u20131546 (2022).","journal-title":"N Engl. J. Med."},{"issue":"6","key":"28250_CR12","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/s41579-023-00878-2","volume":"21","author":"PV Markov","year":"2023","unstructured":"Markov, P. V. et al. The evolution of SARS-CoV-2. Nat. Rev. Microbiol. 21 (6), 361\u2013379 (2023).","journal-title":"Nat. Rev. Microbiol."},{"issue":"10309","key":"28250_CR13","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1016\/S0140-6736(21)02183-8","volume":"398","author":"SY Tartof","year":"2021","unstructured":"Tartof, S. Y. et al. Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: A retrospective cohort study. Lancet 398 (10309), 1407\u20131416 (2021).","journal-title":"Lancet"},{"issue":"24","key":"28250_CR14","doi-asserted-by":"publisher","first-page":"e83","DOI":"10.1056\/NEJMoa2114114","volume":"385","author":"H Chemaitelly","year":"2021","unstructured":"Chemaitelly, H. et al. Waning of BNT162b2 vaccine protection against SARS-CoV-2 infection in Qatar. N Engl. J. Med. 385 (24), e83 (2021).","journal-title":"N Engl. J. Med."},{"key":"28250_CR15","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.ijid.2022.03.028","volume":"119","author":"JL Suah","year":"2022","unstructured":"Suah, J. L. et al. Waning COVID-19 vaccine effectiveness for BNT162b2 and coronavac in malaysia: An observational study. Int. J. Infect. Dis. 119, 69\u201376 (2022).","journal-title":"Int. J. Infect. Dis."},{"issue":"10","key":"28250_CR16","doi-asserted-by":"publisher","first-page":"4523","DOI":"10.1111\/jcmm.16462","volume":"25","author":"M Neagu","year":"2021","unstructured":"Neagu, M. et al. Back to basics in COVID-19: Antigens and antibodies\u2014Completing the puzzle. J. Cell. Mol. Med. 25 (10), 4523\u20134533 (2021).","journal-title":"J. Cell. Mol. Med."},{"issue":"6593","key":"28250_CR17","doi-asserted-by":"publisher","first-page":"eabn4947","DOI":"10.1126\/science.abn4947","volume":"376","author":"JRC Pulliam","year":"2022","unstructured":"Pulliam, J. R. C. et al. Increased risk of SARS-CoV-2 reinfection associated with emergence of Omicron in South Africa. Science 376 (6593), eabn4947 (2022).","journal-title":"Science"},{"issue":"12","key":"28250_CR18","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1016\/j.cmi.2021.08.008","volume":"27","author":"C Matuchansky","year":"2021","unstructured":"Matuchansky, C. Mucosal immunity to SARS-CoV-2: A clinically relevant key to Deciphering natural and vaccine-induced defences. Clin. Microbiol. Infect. 27 (12), 1724\u20131726 (2021).","journal-title":"Clin. Microbiol. Infect."},{"issue":"577","key":"28250_CR19","doi-asserted-by":"publisher","first-page":"eabf1555","DOI":"10.1126\/scitranslmed.abf1555","volume":"13","author":"Z Wang","year":"2021","unstructured":"Wang, Z. et al. Enhanced SARS-CoV-2 neutralization by dimeric IgA. Sci. Transl Med. 13 (577), eabf1555 (2021).","journal-title":"Sci. Transl Med."},{"issue":"5","key":"28250_CR20","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/j.cell.2022.02.005","volume":"185","author":"S Afkhami","year":"2022","unstructured":"Afkhami, S. et al. Respiratory mucosal delivery of next-generation COVID-19 vaccine provides robust protection against both ancestral and variant strains of SARS-CoV-2. Cell 185 (5), 896\u2013915e19 (2022).","journal-title":"Cell"},{"issue":"1","key":"28250_CR21","doi-asserted-by":"publisher","first-page":"6871","DOI":"10.1038\/s41467-021-27063-4","volume":"12","author":"D Lapuente","year":"2021","unstructured":"Lapuente, D. et al. Protective mucosal immunity against SARS-CoV-2 after heterologous systemic prime-mucosal boost immunization. Nat. Commun. 12 (1), 6871 (2021).","journal-title":"Nat. Commun."},{"issue":"1","key":"28250_CR22","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/s41541-023-00654-6","volume":"8","author":"JM Knisely","year":"2023","unstructured":"Knisely, J. M. et al. Mucosal vaccines for SARS-CoV-2: Scientific gaps and opportunities\u2014workshop report. Npj Vaccines. 8 (1), 53 (2023).","journal-title":"Npj Vaccines"},{"issue":"577","key":"28250_CR23","doi-asserted-by":"publisher","first-page":"eabd2223","DOI":"10.1126\/scitranslmed.abd2223","volume":"13","author":"D Sterlin","year":"2021","unstructured":"Sterlin, D. et al. IgA dominates the early neutralizing antibody response to SARS-CoV-2. Sci. Transl Med. 13 (577), eabd2223 (2021).","journal-title":"Sci. Transl Med."},{"issue":"2","key":"28250_CR24","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/jmv.20173","volume":"74","author":"Y Asahi-Ozaki","year":"2004","unstructured":"Asahi-Ozaki, Y. et al. Secretory IgA antibodies provide cross-protection against infection with different strains of influenza B virus. J. Med. Virol. 74 (2), 328\u2013335 (2004).","journal-title":"J. Med. Virol."},{"issue":"14","key":"28250_CR25","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1056\/NEJMc2209651","volume":"387","author":"S Havervall","year":"2022","unstructured":"Havervall, S. et al. Anti-Spike mucosal IgA protection against SARS-CoV-2 Omicron infection. N Engl. J. Med. 387 (14), 1333\u20131336 (2022).","journal-title":"N Engl. J. Med."},{"issue":"21","key":"28250_CR26","first-page":"e55","volume":"387","author":"Z Fanglei","year":"2022","unstructured":"Fanglei, Z., Marcotte, Harold Hammarstr\u00f6m, L. & Pan-Hammarstr\u00f6m, Q. Mucosal IgA against SARS-CoV-2 Omicron infection. N Engl. J. Med. 387 (21), e55 (2022).","journal-title":"N Engl. J. Med."},{"issue":"4","key":"28250_CR27","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/j.femsre.2004.12.001","volume":"29","author":"HA Hong","year":"2005","unstructured":"Hong, H. A., Duc, L. H. & Cutting, S. M. The use of bacterial spore formers as probiotics. FEMS Microbiol. Rev. 29 (4), 813\u2013835 (2005).","journal-title":"FEMS Microbiol. Rev."},{"issue":"3","key":"28250_CR28","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1111\/j.1365-2672.2005.02736.x","volume":"101","author":"P Setlow","year":"2006","unstructured":"Setlow, P. Spores of Bacillus subtilis: Their resistance to and killing by radiation, heat and chemicals. J. Appl. Microbiol. 101 (3), 514\u2013525 (2006).","journal-title":"J. Appl. Microbiol."},{"issue":"5","key":"28250_CR29","doi-asserted-by":"publisher","first-page":"e0010223","DOI":"10.1128\/jb.00102-23","volume":"205","author":"J St\u00fclke","year":"2023","unstructured":"St\u00fclke, J., Gr\u00fcppen, A., Bramkamp, M. & Pelzer, S. Bacillus subtilis, a Swiss army knife in science and biotechnology. J. Bacteriol. 205 (5), e0010223 (2023).","journal-title":"J. Bacteriol."},{"issue":"6","key":"28250_CR30","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.3390\/vaccines11061106","volume":"11","author":"N-A MatRahim","year":"2023","unstructured":"MatRahim, N-A. et al. TonB-Dependent receptor protein displayed on spores of Bacillus subtilis stimulates protective immune responses against Acinetobacter baumannii. Vaccines 11 (6), 1106 (2023).","journal-title":"Vaccines"},{"issue":"11","key":"28250_CR31","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.3390\/vaccines10111900","volume":"10","author":"PM Katsande","year":"2022","unstructured":"Katsande, P. M. et al. Heterologous systemic Prime\u2013Intranasal boosting using a spore SARS-CoV-2 vaccine confers mucosal immunity and Cross-Reactive antibodies in mice as well as protection in hamsters. Vaccines 10 (11), 1900 (2022).","journal-title":"Vaccines"},{"key":"28250_CR32","doi-asserted-by":"publisher","first-page":"346","DOI":"10.3389\/fimmu.2018.00346","volume":"9","author":"A Copland","year":"2018","unstructured":"Copland, A. et al. Mucosal delivery of fusion proteins with Bacillus subtilis spores enhances protection against tuberculosis by Bacillus Calmette-Gu\u00e9rin. Front. Immunol. 9, 346 (2018).","journal-title":"Front. Immunol."},{"issue":"1","key":"28250_CR33","doi-asserted-by":"publisher","first-page":"e87454","DOI":"10.1371\/journal.pone.0087454","volume":"9","author":"RD De Souza","year":"2014","unstructured":"De Souza, R. D. et al. Bacillus subtilis spores as vaccine adjuvants: Further insights into the mechanisms of action. PLoS One. 9 (1), e87454 (2014).","journal-title":"PLoS One"},{"key":"28250_CR34","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.vaccine.2004.05.001","volume":"22","author":"A Ciabattini","year":"2004","unstructured":"Ciabattini, A., Parigi, R., Isticato, R., Oggioni, M. R. & Pozzi, G. Oral priming of mice by Recombinant spores of Bacillus subtilis. Vaccine 22, 31\u201332 (2004).","journal-title":"Vaccine"},{"issue":"6","key":"28250_CR35","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1002\/eji.200636875","volume":"37","author":"AGC Barnes","year":"2007","unstructured":"Barnes, A. G. C., Cerovic, V., Hobson, P. S. & Klavinskis, L. S. Bacillus subtilis spores: A novel microparticle adjuvant which can instruct balanced Th1 and Th2 immune response to specific antigen. Eur. J. Immunol. 37 (6), 1538\u20131547 (2007).","journal-title":"Eur. J. Immunol."},{"key":"28250_CR36","doi-asserted-by":"crossref","unstructured":"Saperi, A. A. et al. Immunization with inactivated Bacillus subtilis spores expressing TonB-Dependent receptor (TBDR) protects against Multidrug-Resistant acinetobacter baumannii infection. 1\u201322. (2025).","DOI":"10.3390\/vaccines13060616"},{"issue":"3","key":"28250_CR37","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/s41579-020-00468-6","volume":"19","author":"P V\u2019kovski","year":"2021","unstructured":"V\u2019kovski, P., Kratzel, A., Steiner, S., Stalder, H. & Thiel, V. Coronavirus biology and replication: implications for SARS-CoV-2. Nat. Rev. Microbiol. 19 (3), 155\u2013170 (2021).","journal-title":"Nat. Rev. Microbiol."},{"key":"28250_CR38","first-page":"203205","volume":"2020","author":"Y Li","year":"2020","unstructured":"Li, Y., Jin, L., Chen, T. & Pirozzi, C. J. The effects of secretory IgA in the mucosal immune system. Biomed. Res. Int. 2020, 203205 (2020).","journal-title":"Biomed. Res. Int."},{"key":"28250_CR39","doi-asserted-by":"publisher","first-page":"103788","DOI":"10.1016\/j.ebiom.2021.103788","volume":"75","author":"L Azzi","year":"2022","unstructured":"Azzi, L. et al. Mucosal immune response in BNT162b2 COVID-19 vaccine recipients. eBioMedicine 75, 103788 (2022).","journal-title":"eBioMedicine"},{"key":"28250_CR40","doi-asserted-by":"publisher","first-page":"104435","DOI":"10.1016\/j.ebiom.2022.104435","volume":"88","author":"L Azzi","year":"2023","unstructured":"Azzi, L. et al. Mucosal immune response after the booster dose of the BNT162b2 COVID-19 vaccine. eBioMedicine 88, 104435 (2023).","journal-title":"eBioMedicine"},{"issue":"10","key":"28250_CR41","doi-asserted-by":"publisher","first-page":"e0263861","DOI":"10.1371\/journal.pone.0263861","volume":"17","author":"O Nickel","year":"2022","unstructured":"Nickel, O. et al. Evaluation of the systemic and mucosal immune response induced by COVID-19 and the BNT162b2 mRNA vaccine for SARS-CoV-2. PLoS One. 17 (10), e0263861 (2022).","journal-title":"PLoS One"},{"issue":"76","key":"28250_CR42","doi-asserted-by":"publisher","first-page":"eadd4853","DOI":"10.1126\/sciimmunol.add4853","volume":"7","author":"J Tang","year":"2022","unstructured":"Tang, J. et al. Respiratory mucosal immunity against SARS-CoV-2 after mRNA vaccination. Sci. Immunol. 7 (76), eadd4853 (2022).","journal-title":"Sci. Immunol."},{"issue":"12","key":"28250_CR43","doi-asserted-by":"publisher","first-page":"e2140364","DOI":"10.1001\/jamanetworkopen.2021.40364","volume":"4","author":"AL Beatty","year":"2021","unstructured":"Beatty, A. L. et al. Analysis of COVID-19 vaccine type and adverse effects following vaccination. JAMA Netw. Open. 4 (12), e2140364 (2021).","journal-title":"JAMA Netw. Open."},{"issue":"14","key":"28250_CR44","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1001\/jama.2021.15072","volume":"326","author":"NP Klein","year":"2021","unstructured":"Klein, N. P. et al. Surveillance for adverse events after COVID-19 mRNA vaccination. JAMA 326 (14), 1390\u20131399 (2021).","journal-title":"JAMA"},{"issue":"6","key":"28250_CR45","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/nri1370","volume":"4","author":"L Mayer","year":"2004","unstructured":"Mayer, L. & Shao, L. Therapeutic potential of oral tolerance. Nat. Rev. Immunol. 4 (6), 407\u2013419 (2004).","journal-title":"Nat. Rev. Immunol."},{"issue":"12","key":"28250_CR46","doi-asserted-by":"publisher","first-page":"978","DOI":"10.4161\/hv.6.12.13142","volume":"6","author":"DC Otczyk","year":"2010","unstructured":"Otczyk, D. C. & Cripps, A. W. Mucosal immunization: A realistic alternative. Hum. Vaccin. 6 (12), 978\u20131006 (2010).","journal-title":"Hum. Vaccin"},{"issue":"1","key":"28250_CR47","doi-asserted-by":"publisher","first-page":"205","DOI":"10.3390\/diagnostics12010205","volume":"12","author":"A Ramos","year":"2022","unstructured":"Ramos, A., Cardoso, M. J., Ribeiro, L. & Guimar\u00e3es, J. T. Assessing SARS-CoV-2 neutralizing antibodies after BNT162b2 vaccination and their correlation with SARS-CoV-2 IgG Anti-S1, Anti-RBD and Anti-S2 serological titers. Diagnostics 12 (1), 205 (2022).","journal-title":"Diagnostics"},{"issue":"1","key":"28250_CR48","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.cell.2020.08.026","volume":"183","author":"AO Hassan","year":"2020","unstructured":"Hassan, A. O. et al. A Single-Dose intranasal ChAd vaccine protects upper and lower respiratory tracts against SARS-CoV-2. Cell 183 (1), 169\u2013184e13 (2020).","journal-title":"Cell"},{"issue":"3","key":"28250_CR49","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1038\/s41423-022-00838-5","volume":"19","author":"SJ Choi","year":"2022","unstructured":"Choi, S. J. et al. T cell epitopes in SARS-CoV-2 proteins are substantially conserved in the Omicron variant. Cell. Mol. Immunol. 19 (3), 447\u2013448 (2022).","journal-title":"Cell. Mol. Immunol."},{"issue":"8","key":"28250_CR50","doi-asserted-by":"publisher","first-page":"112888","DOI":"10.1016\/j.celrep.2023.112888","volume":"42","author":"A Muik","year":"2023","unstructured":"Muik, A. et al. Progressive loss of conserved Spike protein neutralizing antibody sites in Omicron sublineages is balanced by preserved T cell immunity. Cell. Rep. 42 (8), 112888 (2023).","journal-title":"Cell. Rep."},{"issue":"9","key":"28250_CR51","doi-asserted-by":"publisher","first-page":"166432","DOI":"10.1016\/j.bbadis.2022.166432","volume":"1868","author":"S Sankaranarayanan","year":"2022","unstructured":"Sankaranarayanan, S., Mohkhedkar, M. & Janakiraman, V. Mutations in Spike protein T cell epitopes of SARS-COV-2 variants: Plausible influence on vaccine efficacy. Biochim. Biophys. Acta - Mol. Basis Dis. 1868 (9), 166432 (2022).","journal-title":"Biochim. Biophys. Acta - Mol. Basis Dis."},{"issue":"1","key":"28250_CR52","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1111\/j.1600-065X.2010.00912.x","volume":"236","author":"IJ Amanna","year":"2010","unstructured":"Amanna, I. J. & Slifka, M. K. Mechanisms that determine plasma cell lifespan and the duration of humoral immunity. Immunol. Rev. 236 (1), 125 (2010).","journal-title":"Immunol. Rev."},{"issue":"2","key":"28250_CR53","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.vaccine.2006.07.025","volume":"25","author":"NQ Uyen","year":"2007","unstructured":"Uyen, N. Q., Hong, H. A. & Cutting, S. M. Enhanced immunisation and expression strategies using bacterial spores as heat-stable vaccine delivery vehicles. Vaccine 25 (2), 356\u2013365 (2007).","journal-title":"Vaccine"},{"issue":"5","key":"28250_CR54","doi-asserted-by":"publisher","first-page":"3114","DOI":"10.4049\/jimmunol.166.5.3114","volume":"166","author":"H Kato","year":"2001","unstructured":"Kato, H., Fujihashi, K., Kato, R., Yuki, Y. & McGhee, J. R. Oral tolerance revisited: prior oral tolerization abrogates cholera Toxin-Induced mucosal IgA responses. J. Immunol. 166 (5), 3114\u20133121 (2001).","journal-title":"J. Immunol."},{"issue":"4","key":"28250_CR55","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/nri1057","volume":"3","author":"AMI Mowat","year":"2003","unstructured":"Mowat, A. M. I. Anatomical basis of tolerance and immunity to intestinal antigens. Nat. Rev. Immunol. 3 (4), 331\u2013341 (2003).","journal-title":"Nat. Rev. Immunol."},{"issue":"13","key":"28250_CR56","doi-asserted-by":"publisher","first-page":"4996","DOI":"10.3390\/molecules28134996","volume":"28","author":"BCL Chan","year":"2023","unstructured":"Chan, B. C. L. et al. Creating a Vaccine-like supplement against respiratory infection using Recombinant Bacillus subtilis spores expressing SARS-CoV-2 Spike protein with natural products. Molecules 28 (13), 4996 (2023).","journal-title":"Molecules"},{"issue":"7","key":"28250_CR57","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.3390\/vaccines10071014","volume":"10","author":"JCC Sung","year":"2022","unstructured":"Sung, J. C. C. et al. Safety and immunogenicity of inactivated Bacillus subtilis spores as a heterologous antibody booster for COVID-19 vaccines. Vaccines 10 (7), 1014 (2022).","journal-title":"Vaccines"},{"issue":"7","key":"28250_CR58","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1016\/j.cell.2020.05.015","volume":"181","author":"A Grifoni","year":"2020","unstructured":"Grifoni, A. et al. Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals. Cell 181 (7), 1489\u20131501e15 (2020).","journal-title":"Cell"},{"issue":"1","key":"28250_CR59","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.cell.2020.08.017","volume":"183","author":"T Sekine","year":"2020","unstructured":"Sekine, T. et al. Robust T cell immunity in convalescent individuals with asymptomatic or mild COVID-19. Cell 183 (1), 158\u2013168e14 (2020).","journal-title":"Cell"},{"issue":"4","key":"28250_CR60","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1016\/j.cell.2020.09.038","volume":"183","author":"C Rydyznski Moderbacher","year":"2020","unstructured":"Rydyznski Moderbacher, C. et al. Antigen-Specific adaptive immunity to SARS-CoV-2 in acute COVID-19 and associations with age and disease severity. Cell 183 (4), 996\u20131012e19 (2020).","journal-title":"Cell"},{"issue":"11","key":"28250_CR61","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1038\/s41590-020-0782-6","volume":"21","author":"Y Peng","year":"2020","unstructured":"Peng, Y. et al. Broad and strong memory CD4\u2009+\u2009and CD8\u2009+\u2009T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19. Nat. Immunol. 21 (11), 1336\u20131345 (2020).","journal-title":"Nat. Immunol."},{"issue":"77","key":"28250_CR62","doi-asserted-by":"publisher","first-page":"eabq7647","DOI":"10.1126\/sciimmunol.abq7647","volume":"7","author":"J Liu","year":"2022","unstructured":"Liu, J. et al. CD8 T cells contribute to vaccine protection against SARS-CoV-2 in macaques. Sci. Immunol. 7 (77), eabq7647 (2022).","journal-title":"Sci. Immunol."},{"issue":"3","key":"28250_CR63","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1038\/s41591-022-01700-x","volume":"28","author":"Y Gao","year":"2022","unstructured":"Gao, Y. et al. Ancestral SARS-CoV-2-specific T cells cross-recognize the Omicron variant. Nat. Med. 28 (3), 472\u2013476 (2022).","journal-title":"Nat. Med."},{"issue":"7901","key":"28250_CR64","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/s41586-022-04465-y","volume":"603","author":"J Liu","year":"2022","unstructured":"Liu, J. et al. Vaccines elicit highly conserved cellular immunity to SARS-CoV-2 Omicron. Nature 603 (7901), 493\u2013496 (2022).","journal-title":"Nature"},{"issue":"6572","key":"28250_CR65","doi-asserted-by":"publisher","first-page":"abm0829","DOI":"10.1126\/science.abm0829","volume":"374","author":"RR Goel","year":"2021","unstructured":"Goel, R. R. et al. mRNA vaccines induce durable immune memory to SARS-CoV-2 and variants of concern. Science 374 (6572), abm0829 (2021).","journal-title":"Science"},{"issue":"21","key":"28250_CR66","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1056\/NEJMc2115596","volume":"385","author":"AY Collier","year":"2021","unstructured":"Collier, A. Y. et al. Differential kinetics of immune responses elicited by Covid-19 vaccines. N Engl. J. Med. 385 (21), 2010\u20132012 (2021).","journal-title":"N Engl. J. Med."},{"issue":"7901","key":"28250_CR67","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1038\/s41586-022-04460-3","volume":"603","author":"R Keeton","year":"2022","unstructured":"Keeton, R. et al. T cell responses to SARS-CoV-2 Spike cross-recognize Omicron. Nature 603 (7901), 488\u2013492 (2022).","journal-title":"Nature"},{"issue":"3","key":"28250_CR68","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/nm.1929","volume":"15","author":"J Sun","year":"2009","unstructured":"Sun, J., Madan, R., Karp, C. L. & Braciale, T. J. Effector T cells control lung inflammation during acute influenza virus infection by producing IL-10. Nat. Med. 15 (3), 277\u2013284 (2009).","journal-title":"Nat. Med."},{"issue":"6","key":"28250_CR69","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1016\/j.immuni.2016.05.006","volume":"44","author":"J Zhao","year":"2016","unstructured":"Zhao, J. et al. Airway memory CD4\u2009+\u2009T cells mediate protective immunity against emerging respiratory coronaviruses. Immunity 44 (6), 1379\u20131391 (2016).","journal-title":"Immunity"},{"issue":"4","key":"28250_CR70","doi-asserted-by":"publisher","first-page":"e20202187","DOI":"10.1084\/jem.20202187","volume":"218","author":"Z Zhuang","year":"2021","unstructured":"Zhuang, Z. et al. Mapping and role of T cell response in SARS-CoV-2-infected mice. J. Exp. Med. 218 (4), e20202187 (2021).","journal-title":"J. Exp. Med."},{"issue":"1","key":"28250_CR71","doi-asserted-by":"publisher","first-page":"3197","DOI":"10.1038\/s41598-022-07149-9","volume":"12","author":"Y Corripio-Miyar","year":"2022","unstructured":"Corripio-Miyar, Y. et al. Functionally distinct T-helper cell phenotypes predict resistance to different types of parasites in a wild mammal. Sci. Rep. 12 (1), 3197 (2022).","journal-title":"Sci. Rep."},{"issue":"3","key":"28250_CR72","first-page":"223","volume":"8","author":"P Kidd","year":"2003","unstructured":"Kidd, P. Th1\/Th2 balance: the hypothesis, its limitations, and implications for health and disease. Altern. Med. Rev. 8 (3), 223\u2013246 (2003).","journal-title":"Altern. Med. Rev."},{"issue":"1","key":"28250_CR73","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4110\/in.2016.16.1.1","volume":"16","author":"H Na","year":"2016","unstructured":"Na, H., Cho, M. & Chung, Y. Regulation of Th2 cell immunity by dendritic cells. Immune Netw. 16 (1), 1\u201312 (2016).","journal-title":"Immune Netw."},{"issue":"8","key":"28250_CR74","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.cels.2022.05.007","volume":"13","author":"S Zhang","year":"2022","unstructured":"Zhang, S. et al. Multiomic analysis reveals cell-type-specific molecular determinants of COVID-19 severity. Cell. Syst. 13 (8), 598\u2013614e6 (2022).","journal-title":"Cell. Syst."},{"key":"28250_CR75","doi-asserted-by":"publisher","first-page":"624483","DOI":"10.3389\/fcimb.2021.624483","volume":"11","author":"FJ Gil-Etayo","year":"2021","unstructured":"Gil-Etayo, F. J. et al. T-Helper cell subset response is a determining factor in COVID-19 progression. Front. Cell. Infect. Microbiol. 11, 624483 (2021).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"28250_CR76","doi-asserted-by":"publisher","first-page":"706902","DOI":"10.3389\/fgene.2021.706902","volume":"12","author":"AB Pavel","year":"2021","unstructured":"Pavel, A. B. et al. Th2\/Th1 cytokine imbalance is associated with higher COVID-19 risk mortality. Front. Genet. 12, 706902 (2021).","journal-title":"Front. Genet."},{"issue":"2","key":"28250_CR77","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.cell.2020.05.042","volume":"182","author":"YJ Hou","year":"2020","unstructured":"Hou, Y. J. et al. SARS-CoV-2 reverse genetics reveals a variable infection gradient in the respiratory tract. Cell 182 (2), 429\u2013446e14 (2020).","journal-title":"Cell"},{"issue":"8","key":"28250_CR78","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1016\/j.immuni.2021.06.018","volume":"54","author":"AT DiPiazza","year":"2021","unstructured":"DiPiazza, A. T. et al. COVID-19 vaccine mRNA-1273 elicits a protective immune profile in mice that is not associated with vaccine-enhanced disease upon SARS-CoV-2 challenge. Immunity 54 (8), 1869\u20131882e6 (2021).","journal-title":"Immunity"},{"issue":"1","key":"28250_CR79","doi-asserted-by":"publisher","first-page":"eabh3827","DOI":"10.1126\/sciadv.abh3827","volume":"8","author":"N Iwata-Yoshikawa","year":"2022","unstructured":"Iwata-Yoshikawa, N. et al. A lethal mouse model for evaluating vaccine-associated enhanced respiratory disease during SARS-CoV-2 infection. Sci. Adv. 8 (1), eabh3827 (2022).","journal-title":"Sci. Adv."},{"issue":"7","key":"28250_CR80","doi-asserted-by":"publisher","first-page":"111214","DOI":"10.1016\/j.celrep.2022.111214","volume":"40","author":"A Ebenig","year":"2022","unstructured":"Ebenig, A. et al. Vaccine-associated enhanced respiratory pathology in COVID-19 hamsters after TH2-biased immunization. Cell. Rep. 40 (7), 111214 (2022).","journal-title":"Cell. Rep."},{"issue":"8","key":"28250_CR81","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1111\/j.1348-0421.2011.00352.x","volume":"55","author":"K Noda","year":"2011","unstructured":"Noda, K. et al. Th17 cells contribute to nontypeable Haemophilus influenzae-specific protective immunity induced by nasal vaccination with P6 outer membrane protein and \u03b1-galactosylceramide. Microbiol. Immunol. 55 (8), 574\u2013581 (2011).","journal-title":"Microbiol. Immunol."},{"issue":"4","key":"28250_CR82","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1084\/jem.194.4.519","volume":"194","author":"P Ye","year":"2001","unstructured":"Ye, P. et al. Requirement of Interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense. J. Exp. Med. 194 (4), 519\u2013527 (2001).","journal-title":"J. Exp. Med."},{"issue":"7","key":"28250_CR83","first-page":"1899","volume":"119","author":"Z Zhang","year":"2009","unstructured":"Zhang, Z., Clarke, T. B. & Weiser, J. N. Cellular effectors mediating Th17-dependent clearance of Pneumococcal colonization in mice. J. Clin. Invest. 119 (7), 1899\u20131909 (2009).","journal-title":"J. Clin. Invest."},{"issue":"7903","key":"28250_CR84","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1038\/s41586-022-04466-x","volume":"603","author":"K Wang","year":"2022","unstructured":"Wang, K. et al. Memory B cell repertoire from triple vaccinees against diverse SARS-CoV-2 variants. Nature 603 (7903), 919\u2013925 (2022).","journal-title":"Nature"},{"issue":"6","key":"28250_CR85","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1016\/j.cell.2022.01.018","volume":"185","author":"K R\u00f6ltgen","year":"2022","unstructured":"R\u00f6ltgen, K. et al. Immune imprinting, breadth of variant recognition, and germinal center response in human SARS-CoV-2 infection and vaccination. Cell 185 (6), 1025\u20131040e14 (2022).","journal-title":"Cell"},{"key":"28250_CR86","doi-asserted-by":"publisher","DOI":"10.1186\/s12866-025-04186-y","volume":"25","author":"A Hazan","year":"2025","unstructured":"Hazan, A. et al. Toxicity study of SARS-CoV-2 Spike protein expressed on Bacillus subtilis spores. BMC Microbiol. 25  633 (2025).","journal-title":"BMC Microbiol."},{"issue":"1","key":"28250_CR87","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s12934-020-01308-1","volume":"19","author":"FDS Santos","year":"2020","unstructured":"Santos, F. D. S. et al. A probiotic treatment increases the immune response induced by the nasal delivery of spore-adsorbed TTFC. Microb. Cell. Fact. 19 (1), 42 (2020).","journal-title":"Microb. Cell. Fact."},{"issue":"1","key":"28250_CR88","doi-asserted-by":"publisher","first-page":"29","DOI":"10.47665\/tb.40.1.009","volume":"40","author":"WH Phoon","year":"2023","unstructured":"Phoon, W. H., Bell-Sakyi, L., AbuBakar, S. & Chang, L. Y. Experimental infection of tick cells with Nipah virus. Trop. Biomed. 40 (1), 29\u201336 (2023).","journal-title":"Trop. Biomed."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-28250-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-28250-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-28250-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T15:05:29Z","timestamp":1777388729000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-28250-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,24]]},"references-count":88,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["28250"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-28250-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,24]]},"assertion":[{"value":"21 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"44552"}}